Consumer Driven Health Care

President Biden's battle against high drug prices, part of the Inflation Reduction Act, is intended to give Medicare patients immediate relief and, in the long term, to regulate what drugmakers charge for their products.

ERISA requires health plans to have unambiguous rules for coverage and exclusion of gender-affirming benefits, however, many health plans deny care under otherwise valid exclusions, for example, cosmetic procedures.

This investment is in the technological aspect and in empowering caregivers, ensuring they have the skills and resources to thrive in this evolving landscape.

The agency is exploring if the companies that broker drug purchases for hospitals, along with the drug distributors, are pushing the prices of generics so low that they've made it hard for manufacturers to maintain production.

Nearly half of those who said they were very concerned about cost ended up not having the procedure done.

The Centers for Medicare & Medicaid Services made "historic strides" in making health care and prescription drugs affordable, said Administrator Chiquita Brooks-LaSure, who updated stakeholders about CMS's accomplishments.

In January, the Biden administration pledged to increase public access to Medicare information to conduct research studies that can influence public health reforms, but this week the CMS announced a proposal to diminish access.

The suit is part of a wave of cases, including suits against UnitedHealth and Cigna, challenging health insurers' denial of coverage for inpatient mental health and substance abuse treatment for mentally ill teenagers and young adults.